Actelis Shareholders Reject 80M Share Authorization — Dilution Plan Blocked
ASNS sits 42% above its 52-week low of $0.03.
Summary
Actelis Networks shareholders rejected a proposal to increase authorized shares from 30M to 80M, blocking a key piece of the company's dilutive financing strategy. Directors and auditor were approved.
Key Events · Corporate Governance and Compliance · ASNS
-
Authorized Share Increase Rejected
Proposal 3 to increase authorized common stock from 30M to 80M shares failed with 5,704,531 votes for and 5,581,190 against — below the required majority of all 25,837,246 outstanding shares.
-
Dilution Capacity Constrained
The rejection limits the company's ability to issue shares under the White Lion Capital financing and delisting-related settlements, which had already resulted in 9.85M securities issued per the August 13 10-Q.
-
Directors Elected
Class I directors Julie Kunstler (1,340,077 for) and Gideon Marks (1,352,835 for) were elected to three-year terms ending 2029.
-
Auditor Ratified
Kesselman & Kesselman (PwC Israel) was ratified as independent auditor for fiscal year 2026 with 9,668,308 votes for.
Analysis · ASNS · Manufacturing
Actelis Networks' shareholders voted down the proposal to increase authorized common stock from 30 million to 80 million shares. The vote fell short of the required majority of all outstanding shares — 5.7 million votes for versus 5.6 million against, with 25.8 million shares outstanding. This is a significant governance event: the company had been pursuing this authorization to accommodate the White Lion Capital financing and delisting-related share issuances. Without the increase, the company's ability to issue the full amount of shares contemplated under those agreements is constrained. The vote also elected two Class I directors and ratified the auditor, but the failed authorization is the headline. The company is already under Nasdaq delisting pressure and has been relying on dilutive financing; this rejection limits its equity-raising capacity at a critical time.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 37.4% of the 3413 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ASNS was trading at $0.04 on OTC in the Manufacturing sector, with a market capitalization of approximately $1.2M. The 52-week trading range was $0.03 to $86.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.